ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $129,843,939 | -3.4% | 1,513,509 | -7.0% | 0.02% | -3.8% |
Q1 2024 | $134,420,339 | +14.0% | 1,627,759 | -7.9% | 0.03% | +8.3% |
Q4 2023 | $117,884,351 | -2.9% | 1,766,852 | -2.3% | 0.02% | -11.1% |
Q3 2023 | $121,417,042 | -3.0% | 1,807,877 | -2.2% | 0.03% | +3.8% |
Q2 2023 | $125,169,512 | +10.1% | 1,848,612 | -12.0% | 0.03% | +4.0% |
Q1 2023 | $113,647,978 | -9.8% | 2,100,702 | -0.2% | 0.02% | -13.8% |
Q4 2022 | $125,939,937 | +26.2% | 2,105,667 | -4.6% | 0.03% | +20.8% |
Q3 2022 | $99,811,000 | -13.4% | 2,206,712 | +7.3% | 0.02% | -7.7% |
Q2 2022 | $115,297,000 | -22.8% | 2,057,035 | -2.0% | 0.03% | -10.3% |
Q1 2022 | $149,314,000 | +45.3% | 2,099,763 | +33.3% | 0.03% | +52.6% |
Q4 2021 | $102,783,000 | -8.4% | 1,574,997 | +5.3% | 0.02% | -13.6% |
Q3 2021 | $112,239,000 | -4.2% | 1,495,746 | -0.3% | 0.02% | -4.3% |
Q2 2021 | $117,112,000 | -4.7% | 1,500,863 | +0.0% | 0.02% | -8.0% |
Q1 2021 | $122,877,000 | +2.0% | 1,500,327 | +3.0% | 0.02% | -3.8% |
Q4 2020 | $120,457,000 | +16.9% | 1,456,714 | -8.2% | 0.03% | +4.0% |
Q3 2020 | $103,062,000 | -9.9% | 1,586,036 | -14.1% | 0.02% | -19.4% |
Q2 2020 | $114,377,000 | +8.9% | 1,846,892 | +12.6% | 0.03% | -11.4% |
Q1 2020 | $105,037,000 | +17.2% | 1,640,449 | +26.8% | 0.04% | +52.2% |
Q4 2019 | $89,641,000 | +9.5% | 1,294,082 | +0.1% | 0.02% | +4.5% |
Q3 2019 | $81,830,000 | -3.5% | 1,293,162 | -3.3% | 0.02% | -4.3% |
Q2 2019 | $84,755,000 | -1.1% | 1,337,673 | -8.9% | 0.02% | -4.2% |
Q1 2019 | $85,723,000 | -6.8% | 1,467,839 | -1.5% | 0.02% | -17.2% |
Q4 2018 | $91,986,000 | -17.7% | 1,490,866 | +4.0% | 0.03% | 0.0% |
Q3 2018 | $111,731,000 | +16.9% | 1,433,372 | +1.5% | 0.03% | +11.5% |
Q2 2018 | $95,594,000 | +5.9% | 1,411,606 | -10.6% | 0.03% | +4.0% |
Q1 2018 | $90,286,000 | – | 1,579,265 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
RK Capital | 115,800 | $7,525,000 | 2.13% |
Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |